Abstract

BackgroundHematopoietic stem cell transplantation is a potential cure for certain life-threatening malignant and nonmalignant diseases. However, experimental and clinical studies have demonstrated that pre-transplant myeloablative conditioning damages the gut leading to translocation of intestinal bacteria and the development of acute graft vs. host disease (aGVHD). The overall objective of this study was to determine whether administration of broad spectrum antibiotics (Abx) affects the onset and/or severity of aGVHD in lymphopenic mice that were not subjected to toxic, pre-transplant conditioning.ResultsWe found that treatment of NK cell-depleted recombination activating gene-1-deficient (-NK/RAG) recipients with an Abx cocktail containing vancomycin and neomycin for 7 days prior to and 4 weeks following adoptive transfer of allogeneic CD4+ T cells, exacerbated the development of aGVHD-induced BM failure and spleen damage when compared to untreated–NK/RAG recipients engrafted with syngeneic or allogeneic T cells. Abx-treated mice exhibited severe anemia and monocytopenia as well as marked reductions in BM- and spleen-residing immune cells. Blinded histopathological analysis confirmed that Abx-treated mice engrafted with allogeneic T cells suffered significantly more damage to the BM and spleen than did untreated mice engrafted with allogeneic T cells. Abx-induced exacerbation of BM and spleen damage correlated with a dramatic reduction in fecal bacterial diversity, marked loss of anaerobic bacteria and remarkable expansion of potentially pathogenic bacteria.ConclusionsWe conclude that continuous Abx treatment may aggravate aGVHD-induced tissue damage by reducing short chain fatty acid-producing anaerobes (e.g. Clostridium, Blautia) and/or by promoting the expansion of pathobionts (e.g. Akkermansia) and opportunistic pathogens (Cronobacter).

Highlights

  • Hematopoietic stem cell transplantation (HSCT) is a potential cure for different life-threatening malignant and nonmalignant diseases [1, 2]

  • We found that treatment of NK cell-depleted recombination activating gene-1-deficient (-NK/ RAG) recipients with an Abx cocktail containing vancomycin and neomycin for 7 days prior to and 4 weeks following adoptive transfer of allogeneic CD4+ T cells, exacerbated the development of acute graft vs. host disease (aGVHD)-induced bone marrow (BM) failure and spleen damage when compared to untreated–NK/ RAG recipients engrafted with syngeneic or allogeneic T cells

  • We found that treatment of NK cell-depleted recombination activating gene-1-deficient (-NK/RAG1) recipients with an Abx cocktail containing vancomycin and neomycin for 7 days prior to and 4 weeks following adoptive transfer of allogeneic CD4+ T cells exacerbated aGVHD-induced bone marrow and spleen damage when compared to untreated mice engrafted with allogeneic or syngeneic T cells

Read more

Summary

Introduction

Hematopoietic stem cell transplantation (HSCT) is a potential cure for different life-threatening malignant and nonmalignant diseases [1, 2]. The likelihood of obtaining siblings or other related family members who are fully or nearly MHC matched with the recipient is only 25% [3] This reality has prompted clinicians to expand the pool of potential donors to include first degree relatives or unrelated donors who share one copy of chromosome 6 containing the MHC loci. The use of allogeneic HSCT donors has greatly expanded the use of HSCT to treat refractory/recurring malignancies or blood disorders, ~50% of patients receiving this treatment will develop a potentially lethal, multi-organ inflammatory disease called acute graft vs host disease (aGVHD) [1]. Experimental and clinical studies have demonstrated that pre-transplant myeloablative conditioning damages the gut leading to translocation of intestinal bacteria and the development of acute graft vs host disease (aGVHD). The overall objective of this study was to determine whether administration of broad spectrum antibiotics (Abx) affects the onset and/or severity of aGVHD in lymphopenic mice that were not subjected to toxic, pre-transplant conditioning

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.